Jessica Hartmann

Title: Jessica Hartmann: Innovator in Targeted T Cell Therapy

Introduction

Jessica Hartmann is a prominent inventor based in Bergisch Gladbach, Germany. She has made significant contributions to the field of immunotherapy, particularly in the development of targeted therapies for T cell subsets. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Jessica Hartmann holds a patent for a "CD62L specific lentiviral vector particle for targeted transduction of T cell subsets." This invention provides a composition that includes a pseudotyped retroviral vector particle. The vector particle comprises an envelope protein with antigen-binding activity, which is crucial for targeting specific T cell subsets. The patent highlights the potential for improved therapeutic strategies in treating various diseases by effectively targeting T cells.

Career Highlights

Jessica is currently employed at Miltenyi Biorec B.V. Co., Kg, where she continues to work on innovative solutions in the field of biotechnology. Her role at the company allows her to collaborate with other experts and contribute to groundbreaking research that has the potential to change the landscape of immunotherapy.

Collaborations

Jessica has worked alongside notable colleagues such as Thomas Schaser and Andrew Kaiser. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Jessica Hartmann is a trailblazer in the realm of targeted T cell therapies, with her patent reflecting her commitment to scientific advancement. Her work at Miltenyi Biorec B.V. Co., Kg, and collaborations with esteemed colleagues further underscore her impact on the field.